RE:RE:RE:webcastInMed Pharma will be reporting some revenues for the first time on 10 Feb and hopefully will give guidance going forward. So far they are supplying CBC and CBT with THCV and CBDV on the way. It's unclear what demand in the market is like. If CBC is that good for depression, I think it would take off. Apparently the market wants all the THCV that can be made. Dissapointed that Willow doesn't seem to want to guide on revenues. They had eluded to their order book being filled 2022.